Moving the Treatment of MPNs Forward: Integration of Recent Data Sets Into Clinical Practice

Explore recent advances and current best practices in managing patients with MPNs in this engaging educational program that includes an on-demand Webcast and downloadable slideset.
Prithviraj Bose, MD
Stephen Oh, MD, PhD

On-Demand Webcast

In this interactive Webcast, Stephen Oh, MD, PhD, offers insights on current best practices and emerging options for treating patients with myeloproliferative neoplasms.

Stephen Oh, MD, PhD Physicians: maximum of 0.75 AMA PRA Category 1 Credits Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Released: April 23, 2020 Expired: April 22, 2021

Downloadable Slideset

Download these slides from our live meeting series to review key strategies for managing patients with MPNs.

Prithviraj Bose, MD Stephen Oh, MD, PhD Released: December 19, 2019
Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley

Supported by an educational grant from
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.


More info

CCO’s educational programs are available completely free of charge on the,, and Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?